ATE485271T1 - Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung - Google Patents

Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung

Info

Publication number
ATE485271T1
ATE485271T1 AT99928753T AT99928753T ATE485271T1 AT E485271 T1 ATE485271 T1 AT E485271T1 AT 99928753 T AT99928753 T AT 99928753T AT 99928753 T AT99928753 T AT 99928753T AT E485271 T1 ATE485271 T1 AT E485271T1
Authority
AT
Austria
Prior art keywords
piperided
anthistaminic
derivatives
production
intermediate products
Prior art date
Application number
AT99928753T
Other languages
English (en)
Inventor
Timothy Ayers
Paul Brown
Original Assignee
Aventisub Ii Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22328222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE485271(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventisub Ii Inc filed Critical Aventisub Ii Inc
Application granted granted Critical
Publication of ATE485271T1 publication Critical patent/ATE485271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99928753T 1998-07-02 1999-06-17 Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung ATE485271T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10954298A 1998-07-02 1998-07-02
PCT/US1999/013693 WO2000001671A2 (en) 1998-07-02 1999-06-17 Antihistaminic piperidine derivatives and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE485271T1 true ATE485271T1 (de) 2010-11-15

Family

ID=22328222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99928753T ATE485271T1 (de) 1998-07-02 1999-06-17 Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung

Country Status (20)

Country Link
EP (1) EP1091938B1 (de)
JP (1) JP2002519411A (de)
KR (2) KR100707904B1 (de)
CN (3) CN100522921C (de)
AR (1) AR019197A1 (de)
AT (1) ATE485271T1 (de)
AU (1) AU769284B2 (de)
BR (1) BR9911794A (de)
CA (1) CA2336380C (de)
DE (1) DE69942876D1 (de)
DK (1) DK1091938T3 (de)
ES (1) ES2354968T3 (de)
HU (1) HUP0104159A3 (de)
IL (6) IL140649A0 (de)
NO (1) NO319534B1 (de)
NZ (2) NZ528839A (de)
PT (1) PT1091938E (de)
TW (1) TW533197B (de)
WO (1) WO2000001671A2 (de)
ZA (1) ZA200007034B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532356A (ja) 2002-06-10 2005-10-27 テバ ファーマシューティカル インダストリーズ リミティド 塩酸フェキソフェナジンの多型体ｘｖｉ
CN101585768B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸酯的方法
CN101585763B (zh) * 2009-06-06 2012-01-04 浙江大学宁波理工学院 一种合成2-[4-(4-氯丁酰基)苯基]-2-甲基丙酸的方法
CN101585767B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 一种合成2—[4—(4—氯丁酰基)苯基]—2—甲基丙酸酯的方法
CN101585764B (zh) * 2009-06-06 2012-02-15 浙江大学宁波理工学院 合成2—［4—(4—氯丁酰基)苯基］—2—甲基丙酸的方法
EP2289867A3 (de) * 2009-08-19 2012-04-25 Jubilant Organosys Limited Verfahren zur Herstellung von 4-(4-Halogen-1-oxybutyl)-alpha,alpha-dimethylbenzolessigsäure oder Alkylestern davon
JP6192554B2 (ja) * 2014-02-03 2017-09-06 三菱電機株式会社 真空断熱材の製造方法
CN112661693A (zh) * 2021-01-27 2021-04-16 西北农林科技大学 一种非索非那定的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
HU226561B1 (en) * 1992-04-10 2009-04-28 Merrell Dow Pharma Process for preparation 4-diphenylmethyl piperidine derivatives and the novel intermediates thereof
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
AU670004B2 (en) * 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
EP2261208A1 (de) * 1993-06-25 2010-12-15 Aventisub II Inc. Zwischenprodukte zur Herstellung antihistaminischer 4-Diphenylmethyl-/Diphenylmethoxy- Piperidinderivate
KR19990008406A (ko) * 1995-05-08 1999-01-25 스티븐엘.네스비트 알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도

Also Published As

Publication number Publication date
CA2336380A1 (en) 2000-01-13
WO2000001671A2 (en) 2000-01-13
WO2000001671A3 (en) 2000-04-06
DE69942876D1 (de) 2010-12-02
HK1091806A1 (zh) 2007-01-26
NO20006694L (no) 2001-03-01
ES2354968T3 (es) 2011-03-21
HK1034065A1 (en) 2001-10-12
NO319534B1 (no) 2005-08-29
AR019197A1 (es) 2001-12-26
CN101311165B (zh) 2011-05-18
NO20006694D0 (no) 2000-12-29
IL171063A (en) 2007-09-20
AU769284B2 (en) 2004-01-22
KR100707904B1 (ko) 2007-04-16
NZ528839A (en) 2005-03-24
EP1091938B1 (de) 2010-10-20
IL140649A (en) 2006-08-01
HUP0104159A3 (en) 2002-04-29
TW533197B (en) 2003-05-21
JP2002519411A (ja) 2002-07-02
AU4574699A (en) 2000-01-24
ZA200007034B (en) 2002-04-08
HK1125382A1 (en) 2009-08-07
BR9911794A (pt) 2001-03-27
IL140649A0 (en) 2002-02-10
CA2336380C (en) 2007-04-10
CN1807394A (zh) 2006-07-26
EP1091938A2 (de) 2001-04-18
CN101311165A (zh) 2008-11-26
KR20060035816A (ko) 2006-04-26
KR100682447B1 (ko) 2007-02-16
CN1308611A (zh) 2001-08-15
DK1091938T3 (da) 2011-02-07
KR20010053324A (ko) 2001-06-25
IL171061A (en) 2007-09-20
NZ508477A (en) 2003-12-19
CN100522921C (zh) 2009-08-05
PT1091938E (pt) 2010-12-20
IL171062A (en) 2007-09-20
IL171479A (en) 2007-10-31
HUP0104159A2 (hu) 2002-03-28
CN1246312C (zh) 2006-03-22

Similar Documents

Publication Publication Date Title
DE69929311D1 (de) Oximanderivate und verfahren zu ihrer herstellung
ATE302754T1 (de) Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE247099T1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
ATE216704T1 (de) Propiophenonderivate und verfahren zu ihrer herstellung
ATE222250T1 (de) Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
IS1865B (is) Nýjar erýþrómýsin afleiður, sem og læknislyf sem innihalda þær
DE69903464D1 (de) Haftverschlüsse, deren herstellung und sie aufweisenden produkten
HUP0200312A3 (en) Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
DE69908353D1 (de) Pigmentprodukte
ATE265148T1 (de) Gefrorene süssspeisen und verfahren zu ihrer herstellung
ATE232879T1 (de) Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
PT1023161E (pt) Produto composito termoplastico-elastomero
DE69933307D1 (de) Fliessfähige, wässrige borhaltige zusammensetzungen und verfahren zu ihrer herstellung
ATE332082T1 (de) Insektizide aerosol-zusammensetzung und insektizide zusammensetzung zu ihrer herstellung
DE69801795D1 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
DE60012288D1 (de) Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
DE60123292D1 (de) Uht-milchkonzentratspackung und verfahren zu ihrer herstellung
DE69527779D1 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
ATE485271T1 (de) Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung
DE69523571D1 (de) Pyridylimidazol-derivate und verfahren zu ihrer herstellung
DE69527445D1 (de) Aminooligosaccharid-derivate und verfahren zu ihrer herstellung
ATE209212T1 (de) Aromatische ribose-substituierte derivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel
DE59608892D1 (de) Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
ATE217008T1 (de) Erythromycinderivate, verfahren zu ihrer herstellung, und ihrer verwendung als arzneimitteln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1091938

Country of ref document: EP